On Thursday, Shares of Starbucks Corporation (NASDAQ:SBUX), gain 3.69% to $55.95.
Starbucks Corporation, declared the company will present at the Goldman Sachs Global Retailing Conference on Thursday, September 10, 2015 at 3:10 p.m. ET.
Starbucks Corporation operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; Europe, Middle East, and Africa; China/Asia Pacific; and Channel Development.
Shares of Bristol-Myers Squibb Co (NYSE:BMY), inclined 1.30% to $60.81, during its last trading session.
Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds (ALM.L) and Bristol-Myers Squibb Company (BMY), declared that it has reached a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further developed to treat diseases such as prostate cancer, a leading cause of cancer-related deaths among American men.
Developed by Professor David A. Spiegel, Ph.D., M.D. and his team at Yale University, the proprietary synthetic molecules, known as Antibody Recruiting Molecules (ARMs), work by harnessing the power of the body’s own immune system to treat cancer. The ARMs do this by recruiting antibodies already present in the bloodstream and then leading these antibodies to a specific protein found on the surface of cancer cells. From there, the antibodies perform their natural immune function of destroying the diseased cells.
“Dr. Spiegel’s ARM approach presents a differentiated solution that has strong potential to develop next-generation oncology drugs with improved safety and efficacy,” said Satish Jindal, Chief Executive Officer of ABLS. “We are eager to work with David and Yale on this program. This innovative university technology and associated lead molecules are at the ideal stage that we are seeking, where we can bring to bear the drug discovery and development expertise of ABLS and its partners to accelerate therapies to the clinic.”
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Finally, GasLog Ltd (NYSE:GLOG), ended its last trade with 8.07% gain, and closed at $13.53.
Dynagas Ltd. (“Dynagas”), GasLog Ltd. (“GasLog”, NYSE: GLOG) and Golar LNG Ltd (“Golar”, NASDAQ: GLNG) jointly declare that they have reached an LNG carrier pooling agreement (the “LNG Carrier Pool”) to market their vessels, which are presently operating in the LNG shipping spot market.
The LNG Carrier Pool allows the participating owners to optimise the operation of the pool vessels through improved scheduling ability, cost efficiencies and common marketing. The objective of the LNG Carrier Pool is to serve the transportation requirements of a rapidly growing LNG shipping market by providing customers with reliable, more flexible, and innovative solutions to meet their increasingly complex shipping requirements.
The LNG Carrier Pool - to be named “The Cool Pool” - will initially comprise of 14 modern, high quality and essentially equivalent vessels powered by fuel efficient Tri Fuel Diesel Electric (“TFDE”) propulsion technology. The three owners’ initial vessels eligible for contribution to The Cool Pool will be as follows: Dynagas: 3 vessels; Gaslog: 3 vessels; and Golar: 8 vessels. Each vessel owner will continue to be fully responsible for the manning and technical administration of their respective vessels.
Dynagas Ltd is an operating, trading and ship-administration company established in 2004 performing commercial administration and ship administration services for Dynagas Holding Ltd and Dynagas LNG Partners LP (DLNG).
GasLog Ltd., together with its auxiliaries, owns, operates, and manages vessels in the liquefied natural gas (LNG) market worldwide. It provides maritime services for the transportation of LNG; and LNG vessel administration services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
